Serum Institute seeks Covishield's booster dose approval from DCGI

Serum Institute of India (SII) has sought from India's drug regulator approval for Covishield as a booster dose citing adequate stock of the vaccine in the country and a demand for a booster shot due to the emergence of new coronavirus variants, official sources said.

Serum Institute of India (SII) has sought from India's drug regulator approval for Covishield as a booster dose citing adequate stock of the vaccine in the country and a demand for a booster shot due to the emergence of new coronavirus variants, official sources said. December 01, 2021 at 11:56PM https://ift.tt/3I9Rmt2